Product Images Xphozah 10 Mg

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Xphozah 10 Mg NDC 73154-110 by Ardelyx, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image - xphozah 01

Image - xphozah 01

Image - xphozah 02

Image - xphozah 02

Image - xphozah 03

Image - xphozah 03

Chemical Structure - xphozah 04

Chemical Structure - xphozah 04

Image - xphozah 05

Image - xphozah 05

Image - xphozah 06

Image - xphozah 06

Image - xphozah 07

Image - xphozah 07

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - NDC 73154-110-14 - xphozah 08

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - NDC 73154-110-14 - xphozah 08

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - NDC 73154-110-60 - xphozah 09

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - NDC 73154-110-60 - xphozah 09

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - NDC 73154-110-99 - xphozah 10

PRINCIPAL DISPLAY PANEL - 10 mg Tablet Bottle Label - NDC 73154-110-99 - xphozah 10

This text appears to be a description for a medication called XPHOZAH, specifically the professional sample of XPHOZAH in tablet form. The tablets contain 10 mg of the active ingredient called tenapanor (provided as 10.6 mg of tenapanor hydrochloride). The text includes instructions to dispense and store the medication, as well as precautions to protect it from moisture using a desiccant. It states that XPHOZAH is not for sale, but is available as a professional sample. The recommended dosage and additional prescribing information are not provided in this text. The text also includes information about the distributor, Ardelys, Inc., located in Waltham, MA, USA, and mentions a patent website for XPHOZAH. The text contains a lot number and expiration date, but the specific values are not readable in the .*

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Label - NDC 73154-120-14 - xphozah 11

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Label - NDC 73154-120-14 - xphozah 11

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Label - NDC 73154-120-60 - xphozah 12

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Label - NDC 73154-120-60 - xphozah 12

XPHOZAH is a medication in tablet form, containing tenapanor. The container should be kept away from moisture. It is a prescription-only medicine and should be stored between 20°C to 26°C (68°F to 79°F). The recommended dosage can be found in the Prescribing Information. This medication is produced by Ardelyx, Inc. in Waltham, MA, USA. The expiration date and lot number are also provided.*

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Label - NDC 73154-120-99 - xphozah 13

PRINCIPAL DISPLAY PANEL - 20 mg Tablet Bottle Label - NDC 73154-120-99 - xphozah 13

This is a description of a professional sample of a medication called XPHOZAH (tenapanor). It is not available for sale and is intended for prescription use only. The package contains 14 tablets, each containing the equivalent of 20 mg of tenapanor. The tablets are accompanied by a desiccant to protect them from moisture. It is important to keep this medication out of reach of children. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F). The prescribing information should be consulted for the recommended dosage. The product is distributed by Ardelys, Inc. located in Waltham, MA, USA. Additional patent information can be found at www.XPHOZAH-patents.com. The provided LOT number and expiration date should be used for tracking and ensuring the medication's freshness and efficacy.*

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - NDC 73154-130-14 - xphozah 14

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - NDC 73154-130-14 - xphozah 14

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - NDC 73154-130-60 - xphozah 15

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - NDC 73154-130-60 - xphozah 15

XPHOZAH is a medication in tablet form, with each tablet containing 30 mg of tenapanor, provided as 31.9 mg of tenapanor hydrochloride. It is important to dispense and store XPHOZAH in its original container, with the desiccant, to protect it from moisture. The recommended dosage and other pertinent information can be found in the Prescribing Information. XPHOZAH is distributed by Ardelyx, Inc. and should be stored at controlled room temperature. The GTIN (Global Trade Item Number) and lot number are also provided for reference.*

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - NDC 73154-130-99 - xphozah 16

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - NDC 73154-130-99 - xphozah 16

This is a description for a professional sample medication called "YPHOZAH hydrochi". Each tablet contains the equivalent of 30mg of the active ingredient, tenapanor. It is important to keep this medication out of the reach of children and it is not for sale. The tablets should be stored at a temperature between 20°C to 25°C (66°F to 77°F), with permitted excursions between 15°C to 30°C (53°F to 86°F). The medication is distributed by Ardelyx, Inc. located in Waltham, MA 02451, USA. This medication is available by prescription only and for more information, the prescribing information should be consulted.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.